Creates a national center to boost U.S. medicine making, train workers, and reduce reliance on foreign drug supplies.
This bill would create a new National Biopharmaceutical Manufacturing Center of Excellence. This center would help the U.S. make more of its own medicines, train skilled workers for the biotechnology field, and reduce dependence on foreign supply chains for important drugs. It aims to improve health, national security, and the economy.
Today, there isn't a dedicated national center focused on improving how the U.S. makes biopharmaceutical medicines and trains workers for this field. If this bill passes, the National Institute of Standards and Technology would create such a center, backed by an authorized $120,000,000 for the government's budget year 2026, to boost domestic drug production and workforce skills.
HR 6089 · 119th Congress · November 18, 2025 · AI Summary by gemini-2.5-flash · 8/10
Sign in to see your representatives' phone numbers
3 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.